2009The Chinese Journal of Clinical PharmacologyRequires access

Pharmacokinetics and bioequivalence of navirapine tablets in healthy volunteers

Min Huang

Open publisher page 0 citations

Abstract

Objective To study the pharmacokinetics and bioequivalence of two demostic nevirapine tablets in haealthy volunteers.Methods Twenty healthy volunteers were randomized into two groups,whose plasma concentrations of nevirapine were determined at different time after single oral dose of 200 mg nevirapine tablets by own control by HPLC method,the pharmacokinetic parameters were computed and which were experienced variance analysis.Results The main pharmacokinetic parameters of reference and test navirapine tablets were as follows: tmax were(3.5 ± 2.1),(3.0 ± 1.9) h;Cmax were(2.6 ± 0.5),(2.6 ±0.5) mg·L-1;t1/2 were(57.6 ± 10.4),(58.6 ± 10.2) h;MRT were(55.6 ± 6.5),(56.8 ±5.0)h;AUC0-t were(167.6 ± 36.1),(171.8 ± 32.7) mg·L-1·h;AUC0→∞(169.9 ± 36.6),(174.2 ± 33.1)mg·L-1·h;CL/F(1.2 ± 0.3),(1.2 ± 0.2)L·h-1;Vd/F were(100.3 ± 20.4),(99.4 ± 20.8) L,respectively.The relative bioavailability of the test preparation was(103.7 ± 11.6) %.Conclusion The results shows that the test and reference preparations of nevirapine were bioequivalent.

About this research paper

What this paper is about

Objective To study the pharmacokinetics and bioequivalence of two demostic nevirapine tablets in haealthy volunteers.Methods Twenty healthy volunteers were randomized into two groups,whose plasma concentrations of nevirapine were determined at different time after single oral dose of 200 mg nevirapine tablets by own control by HPLC method,the pharmacokinetic parameters were computed and which were experienced variance analysis.Results The main pharmacokinetic parameters of reference and test navirapine tablets were as follows: tmax were(3.5 ± 2.1),(3.0 ± 1.9) h;Cmax were(2.6 ± 0.5),(2.6 ±0.5) mg·L-1;t1/2 were(57.6 ± 10.4),(58.6 ± 10.2) h;MRT were(55.6 ± 6.5),(56.8 ±5.0)h;AUC0-t were(167.6 ± 36.1),(171.8 ± 32.7) mg·L-1·h;AUC0→∞(169.9 ± 36.6),(174.2 ± 33.1)mg·L-1·h;CL/F(1.2 ± 0.3),(1.2 ± 0.2)L·h-1;Vd/F were(100.3 ± 20.4),(99.4 ± 20.8) L,respectively.The relative bioavailability of the test preparation was(103.7 ± 11.6) %.Conclusion The results shows that the test and reference preparations of nevirapine were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the pharmacokinetics and bioequivalence of two demostic nevirapine tablets in haealthy volunteers.Methods Twenty healthy volunteers were randomized into two groups,whose plasma concentrations of nevirapine were determined at different time after single oral dose of 200 mg nevirapine tablets by own control by HPLC method,the pharmacokinetic parameters were computed and which were experienced variance analysis.Results The main pharmacokinetic parameters of reference and test navirapine tablets were as follows: tmax were(3.5 ± 2.1),(3.0 ± 1.9) h;Cmax were(2.6 ± 0.5),(2.6 ±0.5) mg·L-1;t1/2 were(57.6 ± 10.4),(58.6 ± 10.2) h;MRT were(55.6 ± 6.5),(56.8 ±5.0)h;AUC0-t were(167.6 ± 36.1),(171.8 ± 32.7) mg·L-1·h;AUC0→∞(169.9 ± 36.6),(174.2 ± 33.1)mg·L-1·h;CL/F(1.2 ± 0.3),(1.2 ± 0.2)L·h-1;Vd/F were(100.3 ± 20.4),(99.4 ± 20.8) L,respectively.The relative bioavailability of the test preparation was(103.7 ± 11.6) %.Conclusion The results shows that the test and reference preparations of nevirapine were bioequivalent.

Key concepts: Bioequivalence, Pharmacokinetics, Nevirapine, Cmax, Bioavailability, Pharmacology, Medicine, Human immunodeficiency virus (HIV)

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and bioequivalence of navirapine tablets in healthy volunteers — Research Paper | ScholarLens